Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cti Biopharm Corp
(NQ:
CTIC
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jun 23, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cti Biopharm Corp
< Previous
1
2
3
4
Next >
Incyte Hits Five-Year Low After GSK Snags Approval For A New Jakafi Rival
September 18, 2023
Both companies now sell treatments for myelofibrosis, a rare bone marrow cancer.
Via
Investor's Business Daily
CTI BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of CTI BioPharma Corp. - CTIC
June 06, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
CTI BioPharma Corp. (NASDAQ: CTIC) Climbs to New 52-Week High
May 23, 2023
Via
Investor Brand Network
Top 5 Health Care Stocks That Should Keep You Up At Night
May 23, 2023
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 16, 2023
May 16, 2023
Via
Benzinga
The Latest Analyst Ratings for CTI BioPharma
May 15, 2023
Via
Benzinga
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet
May 11, 2023
Investors are on the hunt for undervalued, underfollowed and emerging stocks and retail traders have countless methods at their disposal to uncover new information. For some, this may be overwhelming.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 11, 2023
May 11, 2023
Via
Benzinga
CTI BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of CTI BioPharma Corp. - CTIC
May 10, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
Dow Falls 90 Points; Mesa Air Group Shares Plummet
May 10, 2023
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite gaining around 1% points on Wednesday. The Dow traded down 0.27% to 33,471.60 while the NASDAQ rose 1.01% to 12,302.61. The...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
May 10, 2023
Via
Benzinga
Nasdaq, S&P 500 Higher As Bond Yields Retreat
May 10, 2023
Investor sentiment is boosted today by a better-than-expected consumer price index (CPI) reading for April.
Via
Talk Markets
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Syneos Health, Inc. (Nasdaq – SYNH), Franchise Group, Inc. (Nasdaq – FRG), CTI BioPharma Corp. (Nasdaq – CTIC), Ruth’s Inc. (Nasdaq – RUTH)
May 10, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
Why MBIA Shares Are Trading Lower By 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
May 10, 2023
Gainers Unique Fabricating, Inc. (NYSE: UFAB) climbed 205% to $0.55 after gaining around 4% on Tuesday.
Via
Benzinga
Crude Oil Down 1%; Microvast Holdings Shares Spike Higher
May 10, 2023
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining over 100 points on Wednesday. The Dow traded down 0.28% to 33,469.12 while the NASDAQ rose 0.75% to 12,270.95. The S&P...
Via
Benzinga
Upstart, Compass, RingCentral And Other Big Stocks Moving Higher On Wednesday
May 10, 2023
U.S. stocks traded mixed, with the Dow Jones dropping around 70 points on Wednesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
CTI BioPharma Corp. (NASDAQ: CTIC) Near Top of Volume Charts in Wednesday Trading
May 10, 2023
Via
Investor Brand Network
Why Shares of CTI BioPharma Are Soaring Wednesday
May 10, 2023
A buyout offer from Swedish Orphan Biovitrum drove up the stock's price.
Via
The Motley Fool
Nasdaq Surges Over 1%; US Inflation Falls In April
May 10, 2023
U.S. stocks traded higher this morning, with the Nasdaq Composite gaining over 100 points on Wednesday.
Via
Benzinga
SYNH Stock Alert: The $7 Billion Reason Syneos Health Is Up Today
May 10, 2023
Syneos Health (SYNH) stock is on the rise Wednesday as investors react to news of a $7.1 billion acquisition deal with a group of investors.
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
May 10, 2023
Via
Benzinga
Why Is SeaStar Medical (ICU) Stock Down 32% Today?
May 10, 2023
SeaStar Medical (ICU) stock is falling on Wednesday after the medical technology company got a rejection letter from the FDA.
Via
InvestorPlace
Why CTI BioPharma Shares Are Trading Higher By 84%; Here Are 20 Stocks Moving Premarket
May 10, 2023
Gainers Unique Fabricating, Inc. (NYSE: UFAB) gained 88.8% to $0.34 in pre-market trading after gaining around 4% on Tuesday.
Via
Benzinga
CTIC STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of CTI BioPharma Corp. Is Fair to Shareholders
May 10, 2023
From
Halper Sadeh LLC
Via
Business Wire
Why Is Babylon (BBLN) Stock Down 57% Today?
May 10, 2023
Babylon (BBLN) stock is falling on Wednesday after the health services company revealed earnings and a plan to go private.
Via
InvestorPlace
Why Is CTI BioPharma (CTIC) Stock Up 85% Today?
May 10, 2023
CTI BioPharma (CTIC) stock is taking off on Wednesday after the company announced a major $1.7 billion acquisition deal with Sobi.
Via
InvestorPlace
European Swedish Orphan Biovitrum To Acquire CTI BioPharma For $1.7B
May 10, 2023
Swedish Orphan Biovitrum AB (OTC: BIOVF) has agreed to acquire CTI BioPharma (NASDAQ: CTIC) for $9.10 per share of common stock in an all-cash transaction, representing an implied equity value of
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
May 10, 2023
It's time for another dive into the biggest pre-market stock movers as we see what shares are on rising and falling on Tuesday!
Via
InvestorPlace
What To Expect When Incyte Reports Q1 Earnings In Almost Two Weeks
April 21, 2023
Incyte Corporation (NASDAQ: INCY) will report Q1 FY23 results on May 2. Investor focus remains on the Opzelura launch, which has faced some hiccups over the first 18 months of launch and began to gain...
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
April 12, 2023
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.